Ken Cacciatore
Stock Analyst at TD Cowen
(0)
# 4924
Out of 5,240 analysts
17
Total ratings
27.27%
Success rate
-31.47%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Arcutis Biotherapeut... | Maintains: Outperform | 65 50 | 13.27 | 276.79% | 2 | Aug 9, 2023 | |
Bausch Health Compan... | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Jun 16, 2023 | |
Takeda Pharmaceutica... | Maintains: Outperform | 30 20 | 13.05 | 53.26% | 4 | May 16, 2023 | |
IVERIC bio | Downgrades: Market Perform | n/a | n/a | n/a | 2 | May 8, 2023 | |
scPharmaceuticals | Initiates Coverage On: Outperform | 25 | 3.42 | 630.99% | 1 | Dec 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 35 | 17.23 | 103.13% | 1 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 5.38 | 829.37% | 1 | Jul 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 5.05 | 890.1% | 1 | Oct 19, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 45 | 35.52 | 26.69% | 1 | Apr 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 23 | 0.51 | 4409.8% | 1 | Mar 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 375 | 5.02 | 7370.12% | 1 | Dec 18, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Sep 22, 2017 |